Hariyanto Timotius Ivan, Rizki Niken Ageng, Kurniawan Andree
Faculty of Medicine, Pelita Harapan University, Karawaci, Tangerang, Indonesia.
Department of Otorhinolaryngology, Faculty of Medicine, Pelita Harapan University, Karawaci, Tangerang, Indonesia.
Int Arch Otorhinolaryngol. 2021 Jan;25(1):e170-e174. doi: 10.1055/s-0040-1719120. Epub 2020 Nov 26.
The number of positive cases and deaths from the coronavirus disease 2019 (COVID-19) is still increasing. The early detection of the disease is very important. Olfactory dysfunction has been reported as the main symptom in part of the patients. To analyze the potential usefulness of anosmia or hyposmia in the detection of the COVID-19 infection. We systematically searched the PubMed Central database using specific keywords related to our aims until July 31st, 2020. All articles published on COVID-19 and anosmia or hyposmia were retrieved. A statistical analysis was performed using the Review Manager (RevMan, Cochrane, London, UK) software, version 5.4. A total of 10 studies involving 21,638 patients were included in the present analysis. The meta-analysis showed that anosmia or hyposmia is significantly associated with positive COVID-19 infections (risk ratio [RR]: 4.56; 95% confidence interval [95%CI]: 3.32-6.24; < 0.00001; I = 78%, random-effects modeling). The presence of anosmia or hyposmia is a good predictor of positive COVID-19 infections. Patients with onset of anosmia or hyposmia should take the test or undergo screening for the possibility of COVID-19 infection.
2019冠状病毒病(COVID-19)的确诊病例数和死亡人数仍在增加。该病的早期检测非常重要。嗅觉功能障碍已被报道为部分患者的主要症状。
为分析嗅觉丧失或嗅觉减退在COVID-19感染检测中的潜在作用。
我们使用与我们的目标相关的特定关键词,系统地检索了截至2020年7月31日的PubMed Central数据库。检索了所有发表的关于COVID-19和嗅觉丧失或嗅觉减退的文章。使用Review Manager(RevMan,Cochrane,英国伦敦)软件5.4版进行统计分析。本分析共纳入10项研究,涉及21638名患者。荟萃分析表明,嗅觉丧失或嗅觉减退与COVID-19阳性感染显著相关(风险比[RR]:4.56;95%置信区间[95%CI]:3.32-6.24;P<0.00001;I²=78%,随机效应模型)。
嗅觉丧失或嗅觉减退的存在是COVID-19阳性感染的良好预测指标。出现嗅觉丧失或嗅觉减退的患者应进行检测或接受COVID-19感染可能性的筛查。